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Abstract
Sickle cell disease (SCD) is associated with progressive multi-organ failure especially, the
brain and kidney and leads to high morbidity and mortality rate. The aim of this study was
to determine the prevalence of renal abnormalities among children with SCD. This cross-
sectional study recruited 212 sickling positive patients comprising of 96 Hb AS, 48 Hb SC,
and 68 Hb SS phenotypes from the Pediatric Unit of Wassa Akropong Government Hospi-
tal, Wassa Akropong, Ghana. Early morning urine and venous blood samples were col-
lected from each participant. Urinalysis was conducted and serum urea and creatinine
levels were estimated. Estimate glomerular filtration rate (eGFR) was calculated using the
Swartz equation. Classification of chronic kidney disease (CKD) was based on ‘The Kidney
Disease: Improving Global Outcomes (KIDIGO)’ criteria. The mean age of the children
were 7.90 years. Serum creatinine (p = 0.0310) and urea (p<0.0001) levels were signifi-
cantly higher among Hb AS participants compared with Hb SS phenotype. The prevalent
indicators of renal abnormalities were proteinuria (26.4%), urine granular cast (5.6%) and
CKD (39.6%). Proteinuria, urine granular cast and CKD were most prevalent among Hb
SS (47.1%, 11.8% and 73.5% respectively) compared with Hb SC (41.7%, 8.3%, and
45.8% respectively) and Hb AS (4.2%, 0.0%, and 14.5%) phenotypes, respectively. Sickle
cell conditions were significantly associated with proteinuria (p<0.0001) and CKD (p =
0.0378). Children with Hb SS [aOR = 5.04, 95% CI (2.47–10.3); p<0.0001] and Hb SC
[aOR = 3.14 95% CI (1.39–7.01); p = 0.0174] were at increased odds of developing CKD
after adjusting for age, BMI and gender. Proteinuria and CKD are associated with sickle
cell disease (Hb SC and Hb SS). Renal function should be routinely monitored for children
with SCD.
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Introduction
Sickle cell disease (SCD) is a major genetic disorder; which occurs due to a mutation in the glo-
bin gene of hemoglobin [1, 2]. It affects millions of people worldwide, but it is particularly
common among sub-Saharan Africans (SSA) [3]. The general prevalence of SCD in Ghana has
remained at 2% and the trait 25% in the population [4]. According to Ohene-Frempong et al.,
[4] the prevalence rate of SCD in Ghana is 1.9% of all births per years and it is responsible for
several premature deaths. The Ghana Health Service claims that SCD was the 37th and 36th
cause of deaths in 2002 and 2003 respectively [5, 6]. High morbidity and mortality is common
with the homozygous HbSS phenotype [7]. Even though clinical manifestation of SCD involves
a wide array of symptoms, recurrent attacks of vaso-occlusive crisis (VOC) is the most com-
mon, which consequently stimulate defects in the renal medulla [8, 9].
Patients with sickle cell anaemia (Hb SS) or sickle cell trait (Hb AS) may present with several
types of renal dysfunction as a result of chronic anaemia leading to hemodynamic changes; and
by the consequences of vaso-occlusion especially in the renal medulla [10, 11]. The disruption
of the distal nephron and medullary function leads to a reduction in renal concentrating capac-
ity, urinary acidification, and impairment in potassium metabolism which are often observed
in these patients [12, 13]. In addition, patients with SCD develop glomerulopathy which can
worsen into renal insufficiency [14]. At the same time, pulmonary hypertension associated
with SCD, leads to hemolytic anemias such as thalassemia, hereditary spherocytosis and parox-
ysmal nocturnal hemoglobinuria [15]. Taken together these complications, the risk of chronic
kidney disease (CKD) or End Stage Renal Disease (ESRD) is certain among SCD patients [16].
Early detection and treatment is necessary to avoid renal complications. However, the risk
factors for progression are not clearly elucidated, but significant albuminuria is a key factor in
progression [17]. Acknowledging the limited resources available for managing the disease in
most parts of tropical Africa, and the lack of accurate data to assess the impact of the SCD on
public health in general, 95% of children born with the disease die before the age of 5 years
[18]. The expensive and high-technological solutions to healthcare development in high
income countries are not best suited to a developing country like Ghana. Thus, investigations
of multi-organ damage are only conducted following an acute inlness or clinical manifestation
of symptoms [4].
Aside the challenges in the management of children with SCD in resource-limited districts
in Ghana, there is the need for ample data on renal dysfunctions as well as early detection to
create awareness for routine check-ups. An earlier study has reported a CKD prevalence of
39.2% [17]. Using the KDIGO guidelines, the prevalence of CKD by haemoglobin phenotype
reported by Ephraim et al., [17] were 40.8% and 30.8% for HbSS and HbSC, respectively.
Therefore, this study determined the prevalence of renal abnormalities among children with
SCD in a highly resource limited setting in Ghana.
Materials and methods
Study design and setting
This cross-sectional study was carried out at the Pediatric Unit of Wassa Akropong Govern-
ment Hospital in the Wassa Amenfi East district of the Western Region of Ghana from August
2016 to September 2017.
Study subjects
A total of 212 known sickle cell positive children comprising of 96 hemoglobin phenotype AS
(HbAS), 48 hemoglobin phenotype SC (HbSC) and 68 hemoglobin phenotype SS (HbSS)
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patients aged five (5) to twelve (12) years. Sickling positive outpatients in a steady state, defined
as patients without febrile symptoms or acute illness, were included in this study. Sickle cell
positive patients with other diagnosed medical conditions such as viral hepatitis B or C, diabe-
tes mellitus, tuberculosis and acute viral infections, urinary tract infections, joint inflammatory
condition or any other chronic infections which may interfere with urine albumin dipstick
analysis were excluded. Patients in vaso-occlusive crises were excluded from the study. Patients
with dipstick results suggestive of either anaemic crises (increased bilirubin) or UTIs infections
were excluded. Structured questionnaire was used to collect socio-demographic data of the
study participants.
Blood collection and biochemical analysis
A volume of three (3) mL of venous blood was taken from the subjects and transferred into gel
separator tubes. Blood was allowed to clot and centrifuged at 1500 g for 3 minutes. Serum urea
and creatinine levels were estimated enzymatically using BS3000M Semi Auto Chemistry ana-
lyser (SINNOWA Medical Science and Technology Co. Ltd.).
Urine collection and biochemical analysis
Early morning urine was collected from each participant into a clean, sterile and leak-proof
container. Urine protein was estimated using a highly sensitive semi-quantitative urine albu-
min dipstick. The Medi-Test Combi 101SGL urinary strips was used for the dipstick analysis
and all 10 parameters evaluated. Dipstick method was done once and results recorded without
repetition of tests to confirm the abnormalities. A drop of decanted urine deposit was observed
under microscope. The following were looked for: Epithelial cells, Pus cells, RBC’s and the var-
ious types of casts and crystal structures.
Estimated glomerular filtration rate (eGFR) and CKD
The updated Schwartz equation [19] was used for calculating estimated glomerular filtration
rate (eGFR) as follow
eGFR ðml=min=1:73m2Þ ¼ 0:413 X height ðcmÞ=serum creatinine ðmg=dlÞ
CKD was classified according to the Kidney Disease Improving Global Outcome (KDIGO);
either decreased eGFR< 60 mL/min/1.73 m2 corresponding to stage 3–5 or evidence of kid-
ney damage (albuminuria, or overt proteinuria) [20]. The various eGFR stages were defined as
follows: Stage 1:�90 ml/min/1.73 m2 (Kidney damage with normal or increased eGFR); Stage
2: 60–89 ml/min/ 1.73m2 (Kidney damage with mildly decreased eGFR); Stage 3a: 45–59 ml/
min/1.73 m2 (mild to moderately decreased eGFR); Stage 3b: 30–44 ml/min/1.73 m2 (moder-
ate to severely decreased eGFR); Stage 4: 15–29 ml/min/1.73 m2 (severely decreased eGFR)
and Stage 5:<15 ml/min/1.73 m2 (Kidney failure) [21].
Anthropometry
Weight and height of children were measured using weighing scale and standiometer respec-
tively. Age and sex-specific BMI percentile of children were categorized as underweight =<5th
percentile; normal weight =>5th, <85th percentile; overweight =�85th percentile and obese =
>95th percentile [22].
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Ethics approval and consent to participate
This study was approved by Ethical Review Board and Disease Control Unit of the Wassa
Akropong Health Directorate and the Management of the Hospital. A written informed con-
sent was obtained from the children as wells as legally authorized representative of children
and confidentiality was maintained. Respondents were assured of confidentiality. In addition,
the privacy rights of human subjects were observed. This study was carried out in accordance
with the Code of Ethics of the World Medical Association (Declaration of Helsinki).
Statistical analysis
The data collected was entered into Microsoft Excel and analyzed in STATA version 14. Data
was presented in frequency (proportion) for categorical variables and mean standard deviation
(SD) for continuous variables. Association between categorical variables was performed using
Chi-square test. Comparison between three independent continuous variables was performed
using One-way ANOVA followed by Tukey Test for multiple comparisons. Logistic regression
model was performed to identify the risk of Hb Phenotype developing CKD. The level of sig-
nificance was set at p<0.05 for all statistical comparisons.
Results
The average age of the children were 7.9 years. Overall, a higher proportion of participants
were 7–8 years (34.9%), followed by 5-6years (28.3%), 9–10 years (21.7%) and 11–12 years
(15.1%). There were more boys compared to girls (55.7% vs. 44.3%). The proportion distribu-
tion of Hb phenotype between boys and girls did not show significant differences (p-value =
0.140). Children with Hb phenotype SS had significantly reduced weight and BMI compared
with Hb AS (p<0.05). A higher proportion of children with Hb phenotype SS were under-
weight (73.5%). BMI status was significantly associated with Hb phenotype (p = 0.001)
[Table 1].
Table 1. General characteristics of study participants.
Characteristics Total (N = 212) Hb variant p-value
AS (N = 96) SC (N = 48) SS (N = 68)
Age (years) (Mean ± SD) 7.90 ± 2.2 7.39 ± 2.0 8.50 ± 2.1 8.206 ± 2.3 0.074
Age Group (year) n (%) 0.210
5–6 60(28.3) 36(37.5) 6(12.5) 18(26.5)
7–8 74(34.9) 32(33.3) 22(45.8) 20(29.4)
9–10 56(21.7) 18(18.8) 8(16.7) 20(29.4)
11–12 32(15.1) 10(10.4) 12(25.0) 10(14.7)
Gender n (%) 0.140
Boys 118(55.7) 52(54.2) 20(41.7) 46(67.6)
Girls 94(44.3) 44(45.8) 28(58.3) 22(32.4)
Height (cm) (Mean ± SD) 135.00 ± 0.1 134.00 ± 0.1 135.00 ± 0.1 134.00 ± 0.1 0.871
Weight(kg) (Mean ± SD) 26.12 ± 1.85 26.24 ± 1.96 24.41 ± 1.91 23.83 ± 1.97� 0.038
BMI(kg/m2) 18.48 ± 1.06 19.58 ± 1.07 18.08 ± 1.13 17.78 ± 0.98� 0.041
BMI percentile 0.001
Under weight(<5th) 102(48.1) 32 (33.3) 20(41.7) 30(73.5)
Normal weight(5th-84th) 110(51.8) 64 (66.6) 28 (58.3) 18(26.5)
Values are presented as frequency (proportion), Mean ± SD (standard deviation).
� indicate significant compared to hemoglobin Phenotype AS (HbAS) group.
BMI: body mass index; Hemoglobin Phenotype SC (Hb SC); Hemoglobin Phenotype SS (HbSS)
https://doi.org/10.1371/journal.pone.0225310.t001
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Table 2 shows the prevalence and association between measures of renal abnormalities and
sickle cell conditions. The overall prevalence of proteinuria was 26.4%. The prevalence was
higher among patients with Hb SS (47.1%) followed by Hb SC (41.7%) and Hb AS (4.2%).
There was a significant association between proteinuria and SCDs (p-value = 0.0004). The
overall prevalence of urine granular cast was 5.6%. The prevalence was slightly higher among
Hb SS participants (11.8%) compared with Hb SC (8.3%). No granular cast was observed for
Hb AS participants. Using the KIDIGO criteria, the overall prevalence of CKD was 39.6%. The
highest prevalence of CKD was observed among patient with Hb SS phenotype (73.5%) fol-
lowed by Hb SC (45.8%) and Hb AS participants (14.5%). There was a significant association
between CKD and sickle cell conditions (p = 0.0378).
Children with Hb SS phenotype were at 5 times increase odds of developing CKD
[aOR = 5.04, 95% CI (2.47–10.3); p<0.0001] while Hb SC children were at 3 times increased
odds of developing CKD [aOR = 3.14 95% CI (1.39–7.01); p = 0.0174] after adjusting for age,
BMI and gender [Table 3].
Fig 1 depicts the serum creatinine levels compared among Hb phenotype; Serum creatinine
levels were significantly lower among Hb SS participants compared to their Hb AS counterpart
(p = 0.0310). However, there were no statistically significant difference between: Hb AS and
Hb SC (p = 0.1862); and Hb SC vs. Hb SS (p = 0.1402).
Fig 2 also shows the serum levels of urea compared among Hb phenotypes; the levels of
serum urea among Hb SS participants were higher compared to Hb AS (p<0.0001). Con-
versely, serum urea levels between: Hb AS and SC (p = 0.1516); and Hb SC and Hb SS
(p = 0.1410), participants did not significantly differ.




AS (N = 96) SC (N = 48) SS (N = 68)
Urine Protein (albumin) 0.0004
Negative 156(73.5) 92(95.8) 28(58.3) 36(52.9)
1+ 14(6.7) 2(2.1) 6(12.5) 6(8.8)
2++ 20(9.4) 2(2.1) 8(16.7) 10(14.7)
3+++ 22(10.3) 0(0.0) 6(12.5) 16(23.5)
Total proteinuria 56(26.4) 4(4.2) 20(41.7) 32(47.1)
Granular Cast N/A
NIL 200(94.3) 96(100.0) 44(91.7) 60(88.2)
1+ 2(0.9) 0(0.0) 2(4.2) 0(0.0)
2++ 6(2.8) 0(0.0) 2(4.2) 4(5.9)
3+++ 4(1.9) 0(0.0) 0(0.0) 4(5.9)
Total Cast 12(5.6%) 0(0.0) 4(8.3) 8(11.8)
KIDIGO Criteria
CKD, n (%) eGFR 0.0378
Stage 1:�90 + albuminuria 24(11.3) 4(4.2) 6(12.5) 16(23.5)
Stage 2: 60–89 + albuminuria 16(7.5) 2(2.1) 4(8.3) 10(14.7)
45–59 ml/min/1.73 m2 30(14.2) 4(4.2) 12(25.0) 14(20.5)
30–44 ml/min/1.73 m2 14(6.6) 2(2.1) 2(4.2) 10(14.7)
Overall CKD, n (%) eGFR 84(39.6) 14(14.6) 22(45.8) 50(73.5)
No CKD 128(60.4) 82(85.4) 26(54.2) 18(26.5)
Values are presented as frequency (proportion). N/A: not applicable; CKD: chronic kidney disease; KDIGO: The Kidney Disease: Improving Global Outcomes
https://doi.org/10.1371/journal.pone.0225310.t002
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Discussion
Sickle Cell Disease (SCD) affects various organ systems in the body, and renal abnormalities
are not an exception [12]. This study determined the prevalence of renal abnormalities among
children with sickle cell conditions in a highly resource limited SCD clinic in Ghana using less
expensive routinely available urinalysis and blood urea and creatinine measurements. The
combined diagnostic performance of eGFR and albuminuria were used for CKD classification.
Table 3. Logistic regression analysis of sickle cell condition and it association with CKD.
CKD cOR p-value aOR p-value
CKD (N = 84) No CKD (N = 128)
Hb Phenotype
AS 14(16.7) 82(65.1) 1 (reference)
SC 22(26.2) 26(20.6) 4.95(1.59–15.42) 0.0080 3.14(1.39–7.01) 0.0174
SS 50(59.5) 18(14.2) 16.3(5.38–49.18) <0.0001 5.04(2.47–10.3) <0.0001
aOR: Age, BMI, gender adjusted odds ratio; cOR: crudes odds ratio
https://doi.org/10.1371/journal.pone.0225310.t003
Fig 1. Serum creatinine levels stratified by Hb phenotype.
https://doi.org/10.1371/journal.pone.0225310.g001
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The characteristics of the study participants indicated, that 48.1% of the children were
underweight and the highest prevalence (73.5%) was observed among children with HbSS phe-
notype. This finding is consistent with the reports of Osei-Yeboah, Rodrigues and Enweronu-
Laryea [23] who reported 61.0% prevalence of malnutrition among children with SCD in
Ghana. A study by Boadu, Ohemeng, and Renner [24] has reported similar findings in recent
years. Whiles underweight could undermine the estimation of eGFR by decreasing creatinine
levels [24], it is also a strong index for chronic renal failure [25, 26]. In Africa, the aetiology of
malnutrition in CKD has been associated with the chronic complications such as frequent cri-
ses, hepatomegaly, renal failure, anaemia and persistent infections [27].
Proteinuria prevalence was high among children with SCD compared with those with the
sickle cell trait (HbAS). A dipstick urinalysis findings by Osei-Yeboah and Rodrigues [28]
among SCD children in an urban setting in Ghana, reported an isolated proteinuria prevalence
of 2.8% which is significantly lower compared with our findings. However, studies Ephraim
et al [17] using the observed a proteinuria prevalence of 39.2% among SCD population in an
urban settlement in Ghana using the dipstick method. These reported inconsistencies can be
associated with age, which was demonstrated by Osei-Yeboah and Rodrigues [28]. Also, the
disparity in findings could be attributed to different population group used across different
studies and other confounding factors. Proteinuria often develops in childhood thus
Fig 2. Serum urea levels stratified Hb phenotypes.
https://doi.org/10.1371/journal.pone.0225310.g002
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preventive and treatment approaches for sickle cell nephropathy should be an emphasis of
pediatric programs [29]
Proteinuria is a strong, independent predictor of renal abnormalities and failure [30]. In a
prospective longitudinal study by Anigilaje and Adedoyin [31] in Nigeria showed that protein-
uria is persistent in HbSS phenotype. Conversely, some studies found no significant associa-
tion between proteinuria and sickle cell disease [24]. However the inconsistencies in reported
findings with proteinuria and SCD, significant proteinuria (which is also the most common
presentation in childhood) is a key factor for CKD progression [32].
The principal factors which influence serum creatinine levels are muscle mass and GFR.
Whereas children with HbSS had the highest prevalence of CKD, the serum creatinine levels
were lower than expected compared to HbAS and HbSC phenotypes. These findings are consis-
tent with previous findings [33–35]. These findings could be attributed to the high prevalence
of underweight among the study children especially HbSS. Malnutrition is associated with
lower creatinine levels and also a risk factor for CKD which could explain the findings of this
study. High urea level designates renal dysfunction [36]. However, the levels of urea observed in
this study were lower in HbSS compared with HbAS. Effective dosage of hydroxyurea is known
to induce nephro-protective effect for SCD; and this is a probable explanation to the reduced
levels of creatinine and urea among HbSS patients compared to Hb AS patients [37].
Various studies have showed that calculation of eGFR using serum creatinine is one of the
best markers for predicting kidney disease progression [13, 38, 39]. Alvarez et al., [37] indi-
cated that eGFR for defining CKD in Children (CKD) with Schwartz formula is the best non-
invasive method. Also, other studies combine the use of eGFR and albuminuria as the best
diagnostic tool for evaluating the progression of renal disease [36, 40]. In this study, the use of
KDIGO criteria for CKD classification detected 39.6% of the children having reduced GFR.
This results is similar to a cross-sectional study in Ghana that observed a CKD prevalence of
39.2% among SCD children [28]. Aside the findings of the study, the study has some limita-
tions. The prevalence of malnutrition among the children could underestimated the eGFR
calculation, hence CKD determination. Also, dipstick method was used for proteinuria evalua-
tion without a second confirmation by spot test or albumin quantitation. Thus, the possibilities
of false positive results. However, evaluation of urinary findings was interpreted with caution
and expertise knowing that the dipstick method was the most available routinely used method
for proteinuria estimation in Ghana. Also, malnutrition is a common feature among SCD chil-
dren in Ghana as indicated earlier. Generally, consistent with literature, this study has shown
that renal abnormalities is associated with children with sickle cell disease.
Conclusion
This study observed proteinuria, granular cast and chronic kidney disease to be prevalent in
the proportions of 26.4%, 5.6% and 39.6%, respectively among sickle cell positive children.
The indices of renal abnormalities were most prevalent among HbSS phenotype, then HbSC
phenotype. Considering highly resource limited settings, the study findings informs possible
renal abnormalities among children with SCD. Hence, renal assessment using routinely avail-
able dipstick and urine concentration findings should be prioritize by pediatricians for early
detection and evaluation.
Supporting information
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(DOCX)
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